Paper39232176
The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma.
Blázquez-Encinas R and 15 others. Cancer Gene Ther, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma. Papers, record 39232176. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39232176
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Eukaryotic Initiation Factor-4A | Major topic |
| Carcinoma, Pancreatic Ductal | Major topic |
| Pancreatic Neoplasms | Major topic |
| Humans | |
| Mice | |
| Animals | |
| RNA Splicing | |
| Exons | |
| Cell Line, Tumor | |
| Gene Expression Regulation, Neoplastic | |
| Cell Proliferation | |
| Female | |
| DEAD-box RNA Helicases |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| BFU2016-80360-R | Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) | PubMed |
Source PubMed
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34789870 | Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data. | Nat Rev Cancer | 2022 | https://conductscience.org/library/papers/34789870 | PubMed |
| 2 | 38049848 | Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery. | J Transl Med | 2023 | https://conductscience.org/library/papers/38049848 | PubMed |
| 3 | 26909576 | Genomic analyses identify molecular subtypes of pancreatic cancer. | Nature | 2016 | https://conductscience.org/library/papers/26909576 | PubMed |
| 4 | 31672935 | eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer. | JCI Insight | 2019 | https://conductscience.org/library/papers/31672935 | PubMed |
| 5 | 31727827 | Cellular RNA surveillance in health and disease. | Science | 2019 | https://conductscience.org/library/papers/31727827 | PubMed |
| 6 | 35513835 | EIF4A3-regulated circ_0087429 can reverse EMT and inhibit the progression of cervical cancer via miR-5003-3p-dependent upregulation of OGN expression. | J Exp Clin Cancer Res | 2022 | https://conductscience.org/library/papers/35513835 | PubMed |
| 7 | 32517083 | A Day in the Life of the Exon Junction Complex. | Biomolecules | 2020 | https://conductscience.org/library/papers/32517083 | PubMed |
| 8 | 25476502 | Transcriptome-wide modulation of splicing by the exon junction complex. | Genome Biol | 2014 | https://conductscience.org/library/papers/25476502 | PubMed |
| 9 | 32559497 | Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer. | Cancer Cell | 2020 | https://conductscience.org/library/papers/32559497 | PubMed |
| 10 | 30470262 | EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis. | Mol Cancer | 2018 | https://conductscience.org/library/papers/30470262 | PubMed |
| 11 | 34869305 | Expression and Functional Roles of Eukaryotic Initiation Factor 4A Family Proteins in Human Cancers. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34869305 | PubMed |
| 12 | 37059070 | Pancreatic cancer: Advances and challenges. | Cell | 2023 | https://conductscience.org/library/papers/37059070 | PubMed |
| 13 | 36417849 | MYC regulates a pan-cancer network of co-expressed oncogenic splicing factors. | Cell Rep | 2022 | https://conductscience.org/library/papers/36417849 | PubMed |
| 14 | 28705809 | The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer. | FASEB J | 2017 | https://conductscience.org/library/papers/28705809 | PubMed |
| 15 | 15361652 | Detection of mycoplasma contaminations. | Methods Mol Biol | 2005 | https://conductscience.org/library/papers/15361652 | PubMed |
| 16 | 34965937 | EIF4A3-Induced circARHGAP29 Promotes Aerobic Glycolysis in Docetaxel-Resistant Prostate Cancer through IGF2BP2/c-Myc/LDHA Signaling. | Cancer Res | 2022 | https://conductscience.org/library/papers/34965937 | PubMed |
| 17 | 34857016 | Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34857016 | PubMed |
| 18 | 31541081 | LINC01232 exerts oncogenic activities in pancreatic adenocarcinoma via regulation of TM9SF2. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31541081 | PubMed |
| 19 | 30744688 | Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E. | J Exp Clin Cancer Res | 2019 | https://conductscience.org/library/papers/30744688 | PubMed |
| 20 | 31069274 | Pharmacological systems analysis defines EIF4A3 functions in cell-cycle and RNA stress granule formation. | Commun Biol | 2019 | https://conductscience.org/library/papers/31069274 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42602702 | Pathophysiological and translational implications of the dysregulation of molecular machineries controlling RNA metabolism in thyrotropinomas. | iScience | 2026 | https://conductscience.org/library/papers/42602702 | PubMed |
| 41873808 | ZXDB Drives Macrophage Inflammatory Programming in Sepsis-Induced Acute Kidney Injury by Recruiting EIF4A3 to Enhance ACACA Translation. | FASEB J | 2026 | https://conductscience.org/library/papers/41873808 | PubMed |
| 41189592 | Specificity of mRNA binding to proteins within the NMD machinery is influenced in cancer. | Front Mol Biosci | 2025 | https://conductscience.org/library/papers/41189592 | PubMed |
| 40641186 | EIF4A3 Promotes Muscle Atrophy and Aging by Inhibiting the FAK Pathway Through NEDD9 mRNA Destabilization. | J Cachexia Sarcopenia Muscle | 2025 | https://conductscience.org/library/papers/40641186 | PubMed |
| 40537911 | EIF4A3-Induced Circ_0092278 Enhances Papillary Thyroid Cancer Cell Malignancy by the PI3K/Akt/mTOR Signaling Pathway. | J Microbiol Biotechnol | 2025 | https://conductscience.org/library/papers/40537911 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| EIF4A3 | 9775 | PubTator's text mining | https://conductscience.org/library/genes/9775 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39232176
GET https://conductscience.org/api/papers/v1/39232176/references?page=2